DK162255C - Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf - Google Patents

Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf

Info

Publication number
DK162255C
DK162255C DK254585A DK254585A DK162255C DK 162255 C DK162255 C DK 162255C DK 254585 A DK254585 A DK 254585A DK 254585 A DK254585 A DK 254585A DK 162255 C DK162255 C DK 162255C
Authority
DK
Denmark
Prior art keywords
plunger pipe
preparation
plate
damper
aural
Prior art date
Application number
DK254585A
Other languages
English (en)
Other versions
DK162255B (da
DK254585A (da
DK254585D0 (da
Inventor
Ulrich Grau
Gerhard Ross
Dietrich Hiller
Horst Paul Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK254585D0 publication Critical patent/DK254585D0/da
Publication of DK254585A publication Critical patent/DK254585A/da
Publication of DK162255B publication Critical patent/DK162255B/da
Application granted granted Critical
Publication of DK162255C publication Critical patent/DK162255C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Luminescent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DK254585A 1984-06-09 1985-06-06 Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf DK162255C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3421615 1984-06-09
DE3421615 1984-06-09
DE3421613 1984-06-09
DE3421613 1984-06-09
DE19843443877 DE3443877A1 (de) 1984-06-09 1984-12-01 Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
DE3443877 1984-12-01

Publications (4)

Publication Number Publication Date
DK254585D0 DK254585D0 (da) 1985-06-06
DK254585A DK254585A (da) 1985-12-10
DK162255B DK162255B (da) 1991-10-07
DK162255C true DK162255C (da) 1992-03-16

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254585A DK162255C (da) 1984-06-09 1985-06-06 Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf

Country Status (16)

Country Link
EP (1) EP0166971B1 (da)
AT (1) ATE50502T1 (da)
AU (1) AU575951B2 (da)
CA (1) CA1258427A (da)
DE (1) DE3576120D1 (da)
DK (1) DK162255C (da)
ES (1) ES8605679A1 (da)
FI (1) FI80596C (da)
GR (1) GR851393B (da)
HU (1) HU200102B (da)
IE (1) IE57998B1 (da)
IL (1) IL75448A (da)
NO (1) NO164277C (da)
NZ (1) NZ212338A (da)
PH (1) PH24118A (da)
PT (1) PT80620B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
DK2498802T3 (da) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Farmaceutisk præparat omfattende en glp-1-agonist, et insulin og en methionin
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
MX369511B (es) 2013-04-03 2019-11-11 Sanofi Sa Tratamiento de la diabetes mellitus mediante formulaciones de insulinas de acción prolongada.
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
CH650677A5 (de) * 1981-08-27 1985-08-15 Lilly Co Eli Gegen diabetes mellitus wirksames pharmazeutisches mittel.
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
AU4292585A (en) * 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
HU200102B (en) 1990-04-28
FI80596B (fi) 1990-03-30
FI80596C (fi) 1990-07-10
DK162255B (da) 1991-10-07
FI852273L (fi) 1985-12-10
PH24118A (en) 1990-03-05
AU4342485A (en) 1985-12-12
ES543972A0 (es) 1986-01-16
ES8605679A1 (es) 1986-01-16
DK254585A (da) 1985-12-10
NO164277B (no) 1990-06-11
IL75448A (en) 1989-07-31
DK254585D0 (da) 1985-06-06
IL75448A0 (en) 1985-10-31
NZ212338A (en) 1989-02-24
AU575951B2 (en) 1988-08-11
EP0166971A1 (de) 1986-01-08
IE851431L (en) 1985-12-09
PT80620A (de) 1985-07-01
EP0166971B1 (de) 1990-02-28
FI852273A0 (fi) 1985-06-06
NO852314L (no) 1985-12-10
GR851393B (en) 1985-11-25
HUT37893A (en) 1986-03-28
NO164277C (no) 1990-09-19
IE57998B1 (en) 1993-06-02
ATE50502T1 (de) 1990-03-15
DE3576120D1 (de) 1990-04-05
CA1258427A (en) 1989-08-15
PT80620B (pt) 1987-10-20

Similar Documents

Publication Publication Date Title
DK254585A (da) Insulinpraeparater, en fremgangsmaade til deres fremstilling og deres anvendelse
GB2192968B (en) Fluid filled elastomeric damping device
IT7869848A0 (it) Valvola per fluidi con strozzatore di flusso
IT1128947B (it) Perfezionamenti nei compressori ermetici per fluidi frigorigeni
GB1503359A (en) Oil lamp
IT1229760B (it) Analizzatore di fluidi con compensazione.
DE69010781D1 (de) Vorrichtung für die Thoraxdrainage.
DE3867204D1 (de) Gummilager.
DE59906300D1 (de) Fluidischer Stossdämpfer
ES2048369T3 (es) Tratamiento de metal liquido.
FR2575052B3 (fr) Dispositif destine a equiper un presentoir, ou similaire, pour servir de support a une serie de tiges de suspension d'articles divers, et meubles presentoirs equipes d'un tel dispositif
DE3681284D1 (de) Schwingungsdaempfer fuer maschinenlagerungen.
BE881461A (fr) Dispositif de controle pour le liquide de refroidissement de compresseurs travaillant avec injection de liquide
DE3769974D1 (de) Feuerfeste plastikstruktur.
SE8105745L (sv) Borttagbar tetning for askfickor och liknande
IT8917412A0 (it) Metodo per diminuire il peso specifico di un liquido in cui e' immerso un corpo, insufflando gas.
MY101782A (en) Method for removing a volatile material from a liquid and equipment for the working of this method
ES257901U (es) Cabeza tomamuestras para medidor de velocidad de sedimenta- cion de sangre
UA8634A1 (uk) Спосіб видалеhhя рідиhи з вибою свердловиhи
JPS56116938A (en) Buffer
UA39943C2 (uk) Компенсатор енергії
SE8504611D0 (sv) Vattenpump
JPS57157843A (en) Mounting method of rebound rubber in damper
ES288427U (es) Molde para congelar liquidos
ES262731U (es) Soporte de motor de dos camaras con amortiguacion hidraulica.

Legal Events

Date Code Title Description
PUP Patent expired